Horn Kinney has filed 4 insider transactions across 2 companies since February 2023.
Most recent transaction: a grant/award of 161000 shares of Immunome Inc. ($IMNM) on July 29, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| July 29, 2025 | Immunome Inc. | $IMNM | Horn Kinney | CHIEF BUSINESS OFFICER | A | Employee Stock Option (right to buy) | 161000 | $0.00 | 161,000.0000 | 0 | 9999.99% | 0.00% |
| Aug. 9, 2024 | Immunome Inc. | $IMNM | Horn Kinney | CHIEF BUSINESS OFFICER | A | Stock option (right to buy) | 130000 | $0.00 | 130,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 20, 2024 | Immunome Inc. | $IMNM | Horn Kinney | CHIEF BUSINESS OFFICER | A | Stock option (right to buy) | 300000 | $0.00 | 300,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 1, 2023 | Olema Pharmaceuticals, Inc. | $OLMA | Horn Kinney | Chief Business Officer | A | Stock Option (Right to Buy) | 150000 | $0.00 | 150,000.0000 | 0 | 9999.99% | 0.00% |